These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 9255879
1. pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patients. Podzamczer D, Ferrer E, García A, Ramón JM, Niubó J, Santín M, Rufí G, Pérez JL, Martín R, Gudiol F. Scand J Infect Dis; 1997; 29(3):223-7. PubMed ID: 9255879 [Abstract] [Full Text] [Related]
2. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients]. Cartón JA, Maradona JA, de Oña M, Asensi V, Melón S, García-Alcalde ML, Rodríguez-Junquera M, Moreno-Torrico A, de Zárraga M. Med Clin (Barc); 1999 Sep 04; 113(6):205-9. PubMed ID: 10472608 [Abstract] [Full Text] [Related]
3. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS. Chevret S, Scieux C, Garrait V, Dahel L, Morinet F, Modaï J, Decazes JM, Molina JM. Clin Infect Dis; 1999 Apr 04; 28(4):758-63. PubMed ID: 10825035 [Abstract] [Full Text] [Related]
4. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients. Reynes J, Montes B, Atoui N, Segondy M. J Med Virol; 1996 Jul 04; 49(3):195-8. PubMed ID: 8818964 [Abstract] [Full Text] [Related]
5. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay. Lo CY, Ho KN, Yuen KY, Lui SL, Li FK, Chan TM, Lo WK, Cheng IK. Clin Transplant; 1997 Aug 04; 11(4):286-93. PubMed ID: 9267717 [Abstract] [Full Text] [Related]
6. Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS. Torrús D, Portilla J, Hernández-Aguado I, Boix V, Plazas J, Gimeno A, Torromé M, Llopis C, Valls V, Sánchez-Payá J. Eur J Clin Microbiol Infect Dis; 1999 Sep 04; 18(9):630-5. PubMed ID: 10534184 [Abstract] [Full Text] [Related]
7. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation. Iberer F, Tscheliessnigg KH, Halwachs G, Auer T, Wasler A, Petutschnigg B, Müller H, Freigassner M, Allmayr T, Hipmair G. Wien Klin Wochenschr; 1995 Sep 04; 107(23):718-22. PubMed ID: 8560893 [Abstract] [Full Text] [Related]
8. Quantitative CMV antigenemia correlated with ophthalmoscopic screening for CMV retinitis in AIDS patients. Fezza J, Weitzman M, Shoemaker D, Gremillion C, Chen H. Ophthalmic Surg Lasers; 2001 Sep 04; 32(1):81-2. PubMed ID: 11195751 [Abstract] [Full Text] [Related]
19. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma. Schvoerer E, Henriot S, Zachary P, Freitag R, Fuchs A, Fritsch S, Risch S, Meyer N, Caillard S, Lioure B, Stoll-Keller F. J Med Virol; 2005 May 04; 76(1):76-81. PubMed ID: 15778970 [Abstract] [Full Text] [Related]